REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 2nd, 2017 • Endocyte Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 29, 2017, by and among Endocyte, Inc., a Delaware corporation (the “Company”), and ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH, a company organized under the laws of Germany (“ABX”).
WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • October 2nd, 2017 • Endocyte Inc • Pharmaceutical preparations • Delaware
This certifies that, for value received, ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH, a company organized under the laws of Germany (“Holder”), is entitled to subscribe for the number of shares of the Common Stock (as defined below) of Endocyte, Inc., a Delaware corporation (the “Company”), set forth in Section 4 hereto, as may be adjusted from time to time as provided herein.
Development and License AgreementDevelopment and License Agreement • October 2nd, 2017 • Endocyte Inc • Pharmaceutical preparations • New York
This Development and License Agreement (this “Agreement”) is entered into as of September 29, 2017 (the “Effective Date”), by and between Endocyte, Inc., a company organized under the laws of Delaware, US (“Endocyte”), and ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH, a company organized under the laws of Germany (“ABX”). Endocyte and ABX are referred to together as the “Parties.” Capitalized terms used herein, to the extent not otherwise defined, have the meanings specified in Exhibit A.
